alpha4beta2-nicotinic ACh receptor inhibitor (Research Triangle Institute / Virginia Commonwealth University)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namealpha4beta2-nicotinic ACh receptor inhibitor (Research Triangle Institute / Virginia Commonwealth University)
Drug Alias NameRT-9736-102RT-9736-100
ClassificationSmall molecules
Mechanisms of ActionNicotinic receptors antagonists
TargetsNicotinic receptors
Therapy Area/IndicationsTobacco Use Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRti International
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRti InternationalVirginia Commonwealth University
Active IndicationsN/A
Inactive IndicationsTobacco Use Disorder

Other Information

ATC CodeN/A
Related LinksN/A